ALK+ Advanced NSCLC
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer (NCT03596866) | Takeda | 2019-04-19 |
Track ALK+ Advanced NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.